Protective Effects of Fisetin Against 6-OHDA-Induced Apoptosis by Activation of PI3K-Akt Signaling in Human Neuroblastoma SH-SY5Y Cells

被引:0
作者
Ryoko Watanabe
Takumi Kurose
Yuta Morishige
Ko Fujimori
机构
[1] Osaka University of Pharmaceutical Sciences,Laboratory of Pathobiochemistry
[2] Osaka University of Pharmaceutical Sciences,Laboratory of Biodefense and Regulation
[3] Research Institute of Tuberculosis,undefined
来源
Neurochemical Research | 2018年 / 43卷
关键词
Fisetin; 6-OHDA; Caspase; PI3K-Akt; SH-SY5Y cells;
D O I
暂无
中图分类号
学科分类号
摘要
6-Hydroxydopamine (6-OHDA) induces the production of reactive oxygen species (ROS) that are associated with various neurodegenerative diseases such as Parkinson’s disease. 3,3′,4′,7-Tetrahydroxyflavone (fisetin), a plant flavonoid has a variety of physiological effects such as antioxidant activity. In this study, we investigated the molecular mechanism of the neuroprotective effects of fisetin against 6-OHDA-induced cell death in human neuroblastoma SH-SY5Y cells. 6-OHDA-mediated cell toxicity was reduced in a fisetin concentration-dependent manner. 6-OHDA-mediated elevation of the expression of the oxidative stress-related genes such as hemeoxygenase-1, NAD(P)H dehydrogenase quinone 1, NF-E2-related factor 2, and γ-glutamate-cysteine ligase modifier was suppressed by fisetin. Fisetin also lowered the ratio of the proapoptotic Bax protein and the antiapoptotic Bcl-2 protein in SH-SY5Y cells. Moreover, fisetin effectively suppressed 6-OHDA-mediated activation of caspase-3 and caspase-9, which leads to the cell death, while, 6-OHDA-induced caspase-3/7 activity was lowered. Furthermore, fisetin activated the PI3K-Akt signaling, which inhibits the caspase cascade, and fisetin-mediated inhibition of 6-OHDA-induced cell death was negated by the co-treatment with an Akt inhibitor. These results indicate that fisetin protects 6-OHDA-induced cell death by activating PI3K-Akt signaling in human neuronal SH-SY5Y cells. This is the first report that the PI3K-Akt signaling is involved in the fisetin-protected ROS-mediated neuronal cell death.
引用
收藏
页码:488 / 499
页数:11
相关论文
共 226 条
  • [1] Liu Z(2017)Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications Oxid Med Cell Longev 2017 2525967-318
  • [2] Zhou T(2006)Genetics of Parkinson disease: paradigm shifts and future prospects Nat Rev Genet 7 306-242
  • [3] Ziegler AC(2010)The genetics of Parkinson disease J Geriatr Psychiatry Neurol 23 228-491
  • [4] Dimitrion P(2013)The role of oxidative stress in Parkinson’s disease J Parkinsons Dis 3 461-340
  • [5] Zuo L(2006)Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson’s disease Neurochem Int 48 329-253
  • [6] Farrer MJ(2008)Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons BMC Neurosci 9 75-S152
  • [7] Bekris LM(2008)Differential astroglial activation in 6-hydroxydopamine models of Parkinson’s disease Neurosci Res 62 246-271
  • [8] Mata IF(2014)Apoptosis and oxidative stress in neurodegenerative diseases J Alzheimers Dis 42 S125-1683
  • [9] Zabetian CP(2016)Anti-oxidants in parkinson’s disease therapy: a critical point of view Curr Neuropharmacol 14 260-1914
  • [10] Dias V(2014)Pharmacological treatment of Parkinson disease: a review JAMA 311 1670-4188